{
  "case_id": "case_0067",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 47.0,
    "sex": "Female",
    "genderIdentity": "Cisgender Female",
    "ancestry": "European"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesions involving:\n- right optic nerve and left cerebellum.",
      "structured_data": {
        "gt_lesions_english": [
          "left cerebellum",
          "right optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "optic nerve",
            "side": "right",
            "qualifier": null
          },
          {
            "location": "cerebellar hemisphere",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "right optic nerve (cranial nerve II)",
          "left cerebellum"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 2,
        "correctly_identified_count": 2,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 1.0,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\nAgree to also consider:\n- NMOSD (AQP4+), MOGAD and Neurosarcoid.\n\nOther possible differentials:\n- SLE and Neurosyphilis.\n- Also feasible but of low probability: Vasculitis, Susac Syndrome, Sjogren's, ADEM, Beh\u00e7et's, Lymphoma and Lyme.\n\nThe following suggested diagnoses have a low probability of providing a unifying explanation for the full clinical presentation:\n- Paraneoplastic cerebellar degeneration with optic neuropathy (atypical for strictly unilateral cerebellum and unilateral optic nerve involvement)\n- Non-arteritic anterior ischaemic optic neuropathy with left cerebellar infarction (technically feasible explanation for all signs, but proposes multiple separate pathologies; less parsimonious than a unifying diagnosis)\n- Right optic nerve sheath meningioma with left cerebellar neoplasm (technically feasible explanation for all signs, but proposes multiple separate pathologies; less parsimonious than a unifying diagnosis)",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Relapsing-remitting multiple sclerosis",
          "Clinically isolated syndrome due to central nervous system demyelination",
          "Neuromyelitis optica spectrum disorder",
          "Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease",
          "CNS sarcoidosis",
          "Paraneoplastic cerebellar degeneration with optic neuropathy",
          "Non-arteritic anterior ischaemic optic neuropathy with left cerebellar infarction",
          "Right optic nerve sheath meningioma with left cerebellar neoplasm"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [],
        "matched_lesion_dx_keys": [
          "MS",
          "MOGAD",
          "AQP4_NMOSD",
          "Neurosarcoidosis"
        ],
        "missing_lesion_dx_keys": [
          "Syphilis",
          "CNS_Vasculitis",
          "Susac_Syndrome",
          "Autoimmune_Myelitis_Sjogren",
          "ADEM",
          "Autoimmune_Myelitis_SLE",
          "Behcet_Disease",
          "CNS_Lymphoma",
          "Infection_Lyme"
        ],
        "missing_common_names": [
          "Neurosyphilis",
          "SLE"
        ],
        "missing_low_prob_names": [
          "Vasculitis",
          "Susac Syndrome",
          "Sjogren's",
          "ADEM",
          "Beh\u00e7et's",
          "Lymphoma",
          "Lyme"
        ],
        "additional_diagnoses": [
          "Paraneoplastic cerebellar degeneration with optic neuropathy",
          "Non-arteritic anterior ischaemic optic neuropathy with left cerebellar infarction",
          "Right optic nerve sheath meningioma with left cerebellar neoplasm"
        ]
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 1,
        "gt_matched_count": 1,
        "gt_missed_count": 0,
        "gt_coverage_percentage": 1.0,
        "additional_less_plausible_count": 3,
        "comorbidity_missing_count": 0,
        "other_considerations_missed_count": 0,
        "lesion_ddx_total_count": 13,
        "lesion_ddx_matched_count": 4,
        "lesion_ddx_missed_common_count": 2,
        "lesion_ddx_missed_low_prob_count": 7,
        "lesion_ddx_coverage_percentage": 0.3076923076923077
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Brain and Orbits and CSF test for Oligoclonal Bands - would potentially inform a diagnosis/details of multiple sclerosis.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: anti-dsDNA, anti-MOG, ANA, CRP, anti-AQP4, ENA, ACE, HIV, ANCA, syphilis, ESR, CSF (cytology).\n- Could also consider testing: lyme, CSF (flow cytometry), audiometry, fluorescein angiography.",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI of brain and orbits with gadolinium",
          "MRI of cervical and thoracic spinal cord with gadolinium",
          "Visual evoked potentials",
          "Automated perimetry (formal visual field testing)",
          "Optical coherence tomography of both optic nerves and maculae",
          "Lumbar puncture for opening pressure",
          "CSF cell count and differential",
          "CSF protein and glucose",
          "CSF oligoclonal bands and IgG index",
          "CSF cytology",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Serum glucose",
          "HbA1c",
          "Serum vitamin B12",
          "Serum folate",
          "Serum angiotensin-converting enzyme level",
          "Antinuclear antibody",
          "Extractable nuclear antigen panel",
          "Anti-double-stranded DNA antibody",
          "Antineutrophil cytoplasmic antibodies",
          "Serum aquaporin-4 IgG antibody",
          "Serum myelin oligodendrocyte glycoprotein (MOG) IgG antibody",
          "HIV serology",
          "Syphilis serology",
          "Chest X-ray",
          "ECG",
          "Carotid and vertebral artery Doppler ultrasound or MR angiography"
        ],
        "all_identified_ft_keys": [
          "Anti_dsDNA",
          "MOG_Antibodies",
          "CRP",
          "ENA_Panel",
          "MRI_Orbits",
          "LFT",
          "CSF_Opening_Pressure",
          "Vitamin_B12",
          "Serum_ACE",
          "Glucose_HbA1c",
          "CSF_Oligoclonal_Bands",
          "U_and_E",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ECG",
          "CSF_General",
          "FBC",
          "ANA",
          "OCT",
          "MRI_Cervical_Spine",
          "Chest_XRay",
          "Folate",
          "MRI_Thoracic_Spine",
          "ANCA",
          "HIV_Test",
          "CSF_Cytology",
          "Serum_Immunoglobulins",
          "VEP",
          "MRI_Brain",
          "MRA_Head_Neck",
          "ESR",
          "Automated_Visual_Fields",
          "Carotid_Doppler"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [],
        "expected_inv_keys_ddx": [
          "Anti_dsDNA",
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "CSF_Flow_Cytometry",
          "Audiometry",
          "ENA_Panel",
          "Serum_ACE",
          "ANCA",
          "HIV_Test",
          "CSF_Cytology",
          "Fluorescein_Angiography",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "found_inv_keys_ddx": [
          "Anti_dsDNA",
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "AQP4_Antibodies",
          "ENA_Panel",
          "Serum_ACE",
          "HIV_Test",
          "CSF_Cytology",
          "ANCA",
          "Syphilis_Serology",
          "ESR"
        ],
        "missing_inv_keys_ddx": [
          "CSF_Flow_Cytometry",
          "Audiometry",
          "Fluorescein_Angiography",
          "Lyme_Serology"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 3,
        "primary_tests_found_count": 3,
        "primary_tests_missed_count": 0,
        "primary_tests_coverage_percentage": 1.0,
        "ddx_tests_expected_count": 16,
        "ddx_tests_found_count": 12,
        "ddx_tests_coverage_percentage": 0.75
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- Timing of current symptoms not specified, so no indication whether this is a new relapse or an old deficit.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\nDMTs: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "High-dose intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Typical disabling optic neuritis with concurrent cerebellar relapse strongly suggests an acute inflammatory demyelinating episode",
              "Early IV steroids hasten visual and neurological recovery when given within the first couple of weeks",
              "Short-course high-dose steroids are generally safe once sepsis and significant gastrointestinal or metabolic contraindications are excluded"
            ]
          },
          {
            "treatment": "Oral prednisolone taper following IV methylprednisolone",
            "timing": "Delay",
            "reasons": [
              "Commence immediately after completing IV course if no contraindications",
              "Helps prevent rebound of symptoms and allows gradual withdrawal of corticosteroids",
              "Dose and duration should be individualised based on body weight, diabetes risk, and blood pressure control"
            ]
          },
          {
            "treatment": "Proton pump inhibitor for gastroprotection",
            "timing": "Start Now",
            "reasons": [
              "High-dose systemic steroids increase risk of peptic irritation and ulceration",
              "Middle-aged patients have non-trivial baseline gastrointestinal risk",
              "PPIs provide effective prophylaxis during and shortly after steroid therapy"
            ]
          },
          {
            "treatment": "Physiotherapy and occupational therapy for gait and limb ataxia",
            "timing": "Start Now",
            "reasons": [
              "Gait ataxia and left upper limb dysmetria increase fall risk and impair daily activities",
              "Early balance and coordination training improves functional outcomes",
              "Therapists can advise on home safety measures and assistive devices"
            ]
          },
          {
            "treatment": "Initiation of disease-modifying therapy for multiple sclerosis if diagnostic criteria are met (e.g., ocrelizumab, natalizumab, interferon beta, or other appropriate agent)",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of multiple sclerosis based on MRI and CSF findings and evidence of dissemination in time and space",
              "Choice of agent depends on disease activity, comorbidities, pregnancy plans, and patient preference",
              "Baseline screening for infections, vaccination review, and counselling about risks and monitoring are essential before starting"
            ]
          },
          {
            "treatment": "Long-term immunosuppressive maintenance therapy tailored to antibody status if NMOSD or MOG antibody-associated disease is diagnosed (e.g., rituximab, azathioprine, mycophenolate, satralizumab)",
            "timing": "Delay",
            "reasons": [
              "Indicated only if investigations show aquaporin-4 or MOG antibodies or characteristic imaging pattern",
              "Therapy choice must consider efficacy, relapse prevention, and side-effect profile",
              "Requires detailed counselling and regular monitoring of blood counts, liver function, and infection risk"
            ]
          },
          {
            "treatment": "Low-molecular-weight heparin thromboprophylaxis during any inpatient stay",
            "timing": "Start Now",
            "reasons": [
              "Ataxia and unsteady gait may limit mobility, increasing venous thromboembolism risk in hospital",
              "Pharmacologic prophylaxis is low risk in the absence of bleeding diathesis",
              "Widely recommended for neurologically impaired inpatients with reduced mobility"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "High-dose intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Typical disabling optic neuritis with concurrent cerebellar relapse strongly suggests an acute inflammatory demyelinating episode",
              "Early IV steroids hasten visual and neurological recovery when given within the first couple of weeks",
              "Short-course high-dose steroids are generally safe once sepsis and significant gastrointestinal or metabolic contraindications are excluded"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Timing of current symptoms not specified, so no indication whether this is a new relapse or an old deficit.",
                "Safety screen for contraindications like active infection is required before immunosuppression."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- Timing of current symptoms not specified, so no indication whether this is a new relapse or an old deficit.\n\n- Safety screen for contraindications like active infection is required before immunosuppression."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Initiation of disease-modifying therapy for multiple sclerosis if diagnostic criteria are met (e.g., ocrelizumab, natalizumab, interferon beta, or other appropriate agent)",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of multiple sclerosis based on MRI and CSF findings and evidence of dissemination in time and space",
              "Choice of agent depends on disease activity, comorbidities, pregnancy plans, and patient preference",
              "Baseline screening for infections, vaccination review, and counselling about risks and monitoring are essential before starting"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Safety screen for contraindications like active infection is required before immunosuppression.",
                "Need a pregnancy test result."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 2,
          "reasons_acknowledged": 0,
          "reasons_missed": 2,
          "reasons_coverage_percentage": 0.0
        },
        "dmt": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 3,
          "reasons_acknowledged": 2,
          "reasons_missed": 1,
          "reasons_coverage_percentage": 0.6666666666666666
        }
      }
    }
  }
}